Fontan循环患儿的生长发育评估
本研究对210例Fontan循环患儿进行横断面评估,中位年龄11.07岁,中位身高z评分为-0.58。合并蛋白丢失性肠病者身高z评分更低(中位-2.1)。多因素分析显示身高z评分与BMI z评分、Fontan术后时间、父母中位身高、优势体循环心室类型及血清碱性磷酸酶正相关,与已知遗传综合征、蛋白丢失性肠病、兴奋剂或口服类固醇药物使用负相关。
要点
- Fontan循环患儿身高存在轻度缺陷,中位身高z评分为-0.58。
- 合并蛋白丢失性肠病者身高缺陷更显著,中位身高z评分为-2.1。
- 改善体重可能改善低体重患儿的生长发育。
核心结论
- Fontan循环患儿身高存在轻度缺陷,合并蛋白丢失性肠病者缺陷更显著。
- 身高z评分随Fontan术后时间延长而改善。
- 改善体重可能改善低体重患儿的生长发育。
研究设计与样本
- 横断面评估2011年1月至2015年8月多学科Fontan门诊随访的210例患者。
- 中位年龄11.07岁(8.3,14.73岁),43%为女性。
- 138例(65%)为右优势体循环心室,92例(44%)为左心发育不良综合征。
- 完成Fontan循环的中位年龄为31个月(7.6,135.8个月)。
主要发现
- 中位身高z评分为-0.58(-1.75,0.26)。
- 多因素分析显示身高z评分与BMI z评分、Fontan术后时间、父母中位身高、优势体循环心室类型及血清碱性磷酸酶正相关。
- 身高与已知遗传综合征、蛋白丢失性肠病、兴奋剂或口服类固醇药物使用负相关。
临床怎么用
- 应关注Fontan循环患儿的生长发育,尤其合并蛋白丢失性肠病者。
- 改善体重以提升BMI可能是改善低体重患儿生长的可干预因素。
- 生化标志物可能有助于筛查高危群体以强化干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate growth in a population of patients with Fontan circulation. STUDY DESIGN: We performed a cross-sectional evaluation of patients followed in our multidisciplinary Fontan clinic from January 2011 through August 2015. We reviewed the historical data, anthropometry, clinical, and laboratory studies and performed bivariate and multivariate analysis of factors associated with height z score. RESULTS: Patients (n = 210) were included in the study at median age 11.07 years (8.3, 14.73 years) (43% female); 138 (65%) had a dominant right systemic ventricle and 92 (44%) hypoplastic left heart syndrome. Median age at completion of Fontan circulation was 31 months (7.6, 135.8 months). Median height z score was -0.58 (-1.75, 0.26). Twenty-five (12%) had current or past history of protein-losing enteropathy (PLE). Median height z score for those with current or past history of PLE was -2.1 (-2.46, 1.24). Multivariate analysis revealed positive associations between height z score and body mass index z score, time since Fontan, mid-parental height, dominant systemic ventricle type, and serum alkaline phosphatase. Height correlated negatively with known genetic syndrome, PLE, use of stimulant or oral steroid medication. CONCLUSIONS: Children with Fontan circulation have mild deficits in height, with greater deficits in those with PLE. Height z score improves with time postsurgery. Improving weight, leading to improved body mass index, may be a modifiable factor that improves growth in those who are underweight. Biochemical markers may be helpful screening tests for high-risk groups in whom to intensify interventions.
引用
- Mancilla EE, Zielonka B, Roizen JD, et al. Growth in Children with a Fontan Circulation. J Pediatr. 2021. PMID: 33887332. doi:10.1016/j.jpeds.2021.04.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。